CClinicalTrials.gg
CompletedNCT04289324OPEN4HFOVUpdated Aug 6, 2026

Open Lung Maneuvers During High Frequency Oscillatory Ventilation in Preterm Infants

An interventional study of regular lung recruitment in High Frequency Oscillation Ventilation, Extreme Prematurity and Lung Injury, Acute, sponsored by Medical University of Vienna. Completed at 1 site in Austria. Open to participants aged Up to 8 Weeks. Per ClinicalTrials.gov, last updated 2026-08-06.

Sponsored by Medical University of Vienna · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
36
Allocation
Randomized
Ages
Up to 8 Weeks
Sex
All
01

Study summary

To assess whether stepwise oxygenation-guided lung recruitment at regular intervals reduces the oxygen saturation index (OSI = Mean Airway Pressure × Fraction of inspired Oxygen × 100 / peripheral Oxygen Saturation, OSI = MAPxFiO2x100/SpO2) averaged over high frequency oscillation ventilation (HFOV) time in extremely preterm infants.

Read the detailed description

Background: Open lung maneuvers aim to recruit and stabilize the majority of collapsed alveoli, using oxygenation as an indirect variable for lung volume. The stepwise oxygenation-guided lung recruitment procedure during frequency oscillatory ventilation (HFOV) in preterm infants has a low risk of lung hyperinflation and air leak syndrome. Nevertheless, open lung maneuvers at regular intervals during HFOV to maintain or restore oxygenation is not implemented as a routine procedure in the neonatal intensive care.

Aim of the study: To assess whether stepwise oxygenation-guided lung recruitment at regular intervals reduces the oxygen saturation index (OSI = Mean Airway Pressure × Fraction of inspired Oxygen × 100 / peripheral Oxygen Saturation, OSI = MAPxFiO2x100/SpO2) averaged over HFOV time in extremely preterm infants.

Study design: Single center randomized controlled study.

Methods: Thirty-six extremely preterm infants below 28 weeks of gestational age and on high frequency oscillation ventilation receive either stepwise oxygenation-guided lung recruitment maneuver at regular intervals (intervention) and upon decision of the care giving team (intervention group) or lung recruitment maneuver only upon decision of the care giving team (standard, control group). The primary outcome is the oxygen saturation index averaged over HFO ventilation time. The observation time of the HFOV will be limited to at most seven days.

Sample size: Fifteen infants need to be enrolled in each group to have 80% power (at a two-sided alpha level of 5%) to detect a difference of 25% in the oxygen saturation index between the intervention group and the control group.

Main outcome variables: Oxygen saturation index averaged over HFO ventilation time.

Secondary outcome variables: Bronchopulmonary dysplasia (BPD); days of ventilation; oxygen saturation index averaged over ventilation time (HFO and conventional ventilation); the following variables measured before, during and after a single stepwise oxygenation-guided recruitment maneuver: echocardiographic parameters, reactance, relative impedance changes, lung ultrasound measurements, transcutaneous partial carbon dioxide (CO2), blood pressure, heart rate.

02

Conditions studied

  • High Frequency Oscillation Ventilation
  • Extreme Prematurity
  • Lung Injury, Acute

Browse trials for

03

In context

Acute Lung Injury

989 studies on the registry are indexed under Acute Lung Injury; 156 are open to participants now.

This study's enrollment of 36 is below the median of 54 across 561 interventional studies indexed under Acute Lung Injury.

Browse Acute Lung Injury studies →

Lead sponsor

Medical University of Vienna is the lead sponsor of 1,076 studies on the registry; 177 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Up to 8 Weeks
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria: Preterm infants

  • born below 28 weeks of gestational age
  • not older than 29 weeks of postmenstrual age
  • receive HFOV

Exclusion Criteria:

  • known congenital anomalies of the heart, of the lung, and/or of the central nervous system
  • known chromosomal abnormalities
  • participation in other intervention trials
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
36 participants (actual)

Study arms

  • Experimental
    Intervention

    lung recruitment maneuvers performed every twelve hours during HFOV

    Procedure: regular lung recruitment

  • No intervention
    Control

    no regular lung recruitment maneuvers during HFOV

Interventions

  • Procedureregular lung recruitment

    stepwise oxygenation-guided lung recruitment at regular (twelve hours) intervals during high frequency oscillation ventilation

06

What researchers measure

Primary outcomes

  1. HFOV oxygen saturation index

    oxygen saturation index averaged over high frequency oscillation ventilation for not more than seven consecutive days

    Time frame: through study completion, an average 10 weeks

Secondary outcomes

  1. bronchopulmonary dysplasia

    respiratory support at 36 weeks postmenstrual age

    Time frame: through study completion, an average 10 weeks

  2. days of ventilation

    days on conventional and high frequency oscillation ventilation

    Time frame: through study completion, an average 10 weeks

  3. overall oxygen saturation index

    oxygen saturation index averaged over ventilation time

    Time frame: through study completion, an average 10 weeks

07

Study locations

1 site
  • Medical University of Vienna
    Vienna, State of Vienna 1090, Austria
08

References and documents

Publications

  • Rimensberger PC, Pache JC, McKerlie C, Frndova H, Cox PN. Lung recruitment and lung volume maintenance: a strategy for improving oxygenation and preventing lung injury during both conventional mechanical ventilation and high-frequency oscillation. Intensive Care Med. 2000 Jun;26(6):745-55. doi: 10.1007/s001340051242. PubMed 10945393 ↗
  • Rimensberger PC, Beghetti M, Hanquinet S, Berner M. First intention high-frequency oscillation with early lung volume optimization improves pulmonary outcome in very low birth weight infants with respiratory distress syndrome. Pediatrics. 2000 Jun;105(6):1202-8. doi: 10.1542/peds.105.6.1202. PubMed 10835058 ↗
  • De Jaegere A, van Veenendaal MB, Michiels A, van Kaam AH. Lung recruitment using oxygenation during open lung high-frequency ventilation in preterm infants. Am J Respir Crit Care Med. 2006 Sep 15;174(6):639-45. doi: 10.1164/rccm.200603-351OC. Epub 2006 Jun 8. PubMed 16763218 ↗
  • de Waal K, Evans N, van der Lee J, van Kaam A. Effect of lung recruitment on pulmonary, systemic, and ductal blood flow in preterm infants. J Pediatr. 2009 May;154(5):651-5. doi: 10.1016/j.jpeds.2009.01.012. PubMed 19364558 ↗
  • Zannin E, Doni D, Ventura ML, Fedeli T, Rigotti C, Dellaca RL, Tagliabue PE. Relationship between Mean Airways Pressure, Lung Mechanics, and Right Ventricular Output during High-Frequency Oscillatory Ventilation in Infants. J Pediatr. 2017 Jan;180:110-115. doi: 10.1016/j.jpeds.2016.09.015. Epub 2016 Oct 10. PubMed 27745747 ↗
  • Werther T, Kueng E, Aichhorn L, Pummer L, Goeral K, Berger A, Hermon M, Klebermass-Schrehof K. Regular lung recruitment maneuvers during high-frequency oscillatory ventilation in extremely preterm infants: a randomized controlled trial. BMC Pediatr. 2022 Dec 12;22(1):710. doi: 10.1186/s12887-022-03780-7. PubMed 36503480 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 6, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04289324
Lead sponsor
Medical University of Vienna
Responsible party
Tobias Werther (Principal Investigator, Medical University of Vienna) — Principal investigator
First posted
Feb 28, 2020
Start date
Feb 25, 2020
Primary completion
Aug 31, 2025
Completion
Aug 31, 2025
Last update
Aug 6, 2026

Study contacts

Tobias Werther
principal investigator · Medical University of Vienna

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion